Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer ()
By Milind Javle MD, Mitesh J. Borad
Designed for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Dr. Milind Javle of MD Anderson Cancer Center and Dr. Mitesh J. Board of Mayo Clinic helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of investigational targeted agents and combinations of agents.
Are you a healthcare professional seeking a concise yet comprehensive resource on targeted cancer therapy and immunotherapy for gastrointestinal cancer? Look no further than the “Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer” by renowned experts Milind Javle MD and Mitesh J. Borad.
This practical handbook is designed for quick everyday reference and provides a practical overview of the rapidly advancing field of targeted cancer therapy and immunotherapy. Whether you are a physician, oncologist, or researcher, this book will help you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and the clinical performance of investigational targeted agents and combinations of agents.
One of the standout features of this handbook is its coverage of gastrointestinal cancer targets, including stage 1, 2, and 3 trials and preliminary results, as well as approved therapies. This ensures that you have the most up-to-date and relevant information at your fingertips. The book also includes sections on Sequencing Technologies and Targeted and Immunotherapy Agents, making it a comprehensive resource for understanding the latest developments in the field.
What sets this handbook apart is its organization. Information is presented by tumor type, pathway, and drug name, allowing you to approach clinical challenges from any direction. Whether you need information on a specific tumor type or want to explore the most recent developments in a particular pathway, this book has you covered. Additionally, the handbook highlights FDA approvals throughout, ensuring that you are aware of the latest advancements that have received regulatory approval.
In addition to its comprehensive content, the “Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer” is also pocket-sized and color-coded. This makes it extremely convenient and easy to carry with you, allowing you to access information quickly and easily, even in a busy clinical setting.
Ordering the book in digital format further enhances your reading experience. You can read the handbook directly on your preferred device, such as a computer, tablet, or smartphone. Additionally, you have the option to convert the book into an audiobook, allowing you to listen to the content through natural language text-to-speech technology. This feature is particularly useful for busy healthcare professionals who are often on the go and may prefer to consume information in an auditory format.
As for the authors, Milind Javle MD is an expert in gastrointestinal medical oncology and serves as a professor at MD Anderson Cancer Center. His vast knowledge and experience in the field ensure that the content of this handbook is accurate, up-to-date, and clinically relevant. Mitesh J. Borad, another renowned expert in gastrointestinal oncology, is a professor and consultant at Mayo Clinic. Together, they bring their expertise to provide healthcare professionals with a valuable resource for staying abreast of the latest developments in targeted cancer therapy and immunotherapy.
In summary, if you are a healthcare professional involved in the management of gastrointestinal cancer, the “Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer” is a must-have resource. Its comprehensive yet concise content, organization, and pocket-sized format make it the ideal handbook for quick and easy reference. Order your copy today and join the ranks of healthcare professionals who are staying ahead in this rapidly advancing field.
Product Details
- Covers gastrointestinal cancer targets—stage 1, 2, and 3 trials and preliminary results, as well as approved therapies.
- Includes sections on Sequencing Technologies, and Targeted and Immunotherapy Agents.
- Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction.
- Highlights FDA approvals throughout.
- Pocket-sized and color coded to help you find information quickly and easily.
- Read directly on your preferred device(s), such as computer, tablet, or smartphone.
- Easily convert to audiobook, powering your content with natural language text-to-speech.
- Publisher : LWW; First Edition (September 8, 2023)
- Language : English
- : 288 pages
- ISBN-10 : 1975162943
- ISBN-13 : 978-1975162948